Stryker Cash Flow Statement
NYSE: SYKHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Stryker free cash flow
In fiscal 2025, Stryker generated $5.04 billion of operating cash flow and spent $761.0 million on capital expenditures. That left free cash flow of $4.28 billion, a free-cash-flow margin of 17.1% of revenue. Free cash flow was up 22.8% from the prior year's $3.49 billion.
Stryker returned $1.28 billion to shareholders through dividends, equal to 30% of free cash flow. Free cash flow covered dividend payments 3.3 times.
Summary generated from market data by MetaCap's automated system. Methodology
Stryker cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 3.25B | 2.99B | 3.17B | 2.36B | 1.99B | 1.60B | 2.08B | 3.55B | 1.02B | 1.65B |
| Net Income growth (YoY) | +8.45% | -5.43% | +34.22% | +18.25% | +24.70% | -23.24% | -41.37% | +248.33% | -38.07% | +14.45% |
| Depreciation & Amortization | 1.57B | 1.43B | 1.34B | 1.28B | 1.27B | 1.08B | 1.04B | 966.00M | 859.00M | 752.00M |
| Stock-Based Compensation | 243.00M | 229.00M | 205.00M | 168.00M | 171.00M | 142.00M | 127.00M | 119.00M | 113.00M | 97.00M |
| Change in Working Capital | 242.00M | -261.00M | -379.00M | -895.00M | 78.00M | 427.00M | -787.00M | -40.00M | -371.00M | -266.00M |
| Operating Cash Flow | 5.04B | 4.24B | 3.71B | 2.62B | 3.26B | 3.28B | 2.19B | 2.61B | 1.56B | 1.92B |
| Capital Expenditures | -761.00M | -755.00M | -575.00M | -588.00M | -525.00M | -487.00M | -649.00M | -572.00M | -598.00M | -490.00M |
| Investing Cash Flow | -4.87B | -3.00B | -962.00M | -2.92B | -859.00M | -4.70B | -1.46B | -2.86B | -1.61B | -4.19B |
| Dividends Paid | -1.28B | -1.22B | -1.14B | -1.05B | -950.00M | -863.00M | -778.00M | -703.00M | -636.00M | -568.00M |
| Share Repurchases | — | — | — | — | 0 | 0 | -307.00M | -300.00M | -230.00M | -13.00M |
| Debt Issued | 2.98B | 3.01B | 1.24B | 1.50B | 5.00M | 3.29B | 2.64B | 3.13B | 499.00M | 3.45B |
| Debt Repaid | -1.40B | -2.04B | -2.06B | -653.00M | -1.15B | -2.30B | -1.34B | -669.00M | 0 | -750.00M |
| Financing Cash Flow | 113.00M | -525.00M | -1.59B | -749.00M | -2.37B | -11.00M | 3.00M | 1.33B | -794.00M | 2.26B |
| Net Change in Cash | 359.00M | 681.00M | 1.13B | -1.10B | 1.00M | -1.39B | 721.00M | 1.07B | -774.00M | -63.00M |
| Free Cash Flow | 4.28B | 3.49B | 3.14B | 2.04B | 2.74B | 2.79B | 1.54B | 2.04B | 961.00M | 1.43B |
This table shows 10 annual periods of Stryker's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow SYK's reporting calendar. What is a cash flow statement?